Nasdaq stocks posting largest percentage increases
AP - Thu Oct 09, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SSRI: 5.84 (+0.10), BRID: 8.49 (unch), RENT: 72.90 (-1.00), JAXB: 11.82 (+0.62), RDUS: 18.74 (+0.29), DRIV: 16.76 (+0.16), OBCI: 4.26 (+0.17), SSO.TO: 6.56 (+0.10), ACHN: 10.89 (+0.76), AUXL: 30.35 (-0.06), LAKE: 20.69 (-2.91), GTIV: 19.42 (+0.07)
November 28th Options Now Available For Achillion Pharmaceuticals (ACHN)
DividendChannel.com - Thu Oct 09, 10:04AM CDT
Investors in Achillion Pharmaceuticals Inc. saw new options become available today, for the November 28th expiration.
ACHN: 10.89 (+0.76)
Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
GlobeNewswire - Wed Oct 08, 9:23AM CDT
- Late breaker poster presentation will feature updated SVR results from the Phase 2 trial of ACH-3102, NS5A inhibitor, plus sofosbuvir for the eight-week treatment of genotype 1 HCV -
ACHN: 10.89 (+0.76)
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma
at The Street - Fri Oct 03, 8:41AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.
JNJ: 96.78 (-1.43), SGEN: 34.73 (+1.40), CPRX: 2.43 (-0.01), ACHN: 10.89 (+0.76), SNSS: 1.36 (+0.12), BMY: 49.22 (+0.26)
Did Achillion Pharmaceuticals, Inc. Get Left Out in the M&A Cold?
Todd Campbell, The Motley Fool - Motley Fool - Wed Oct 01, 11:37AM CDT
Source: Achillion Pharmaceuticals. Achillion investors are probably shaking their heads wondering what's wrong with their company following Johnson & Johnson 's acquisition of the privately held Alios for $1.7 billion this week. On the...
JNJ: 96.78 (-1.43), GILD: 96.88 (+0.72), ACHN: 10.89 (+0.76)
J&J Buying Alios, Going Up Against Gilead
at Investor's Business Daily - Tue Sep 30, 11:02AM CDT
Medical giant Johnson & Johnson agreed to buy privately held biotech Alios BioPharma for $1.75 billion Tuesday, advancing its presence in viral diseases. Johnson & Johnson (JNJ) stock was up a fraction in morning trading on the stock market today. In...
JNJ: 96.78 (-1.43), VRTX: 101.26 (+0.16), GILD: 96.88 (+0.72), ACHN: 10.89 (+0.76), MRK: 53.43 (-1.30)
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax
at The Street - Tue Sep 30, 8:49AM CDT
What are the motivations behind significant takeovers, like J&J's takeover of Alios Biopharma? And why have companies like Achillion and Novavax been passed over?
JNJ: 96.78 (-1.43), VRTX: 101.26 (+0.16), GILD: 96.88 (+0.72), NVAX: 5.16 (+0.47), ACHN: 10.89 (+0.76)
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver
PR Newswire - Tue Sep 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACHN, DWA, SUNE, LOCO and WFM.
WFM: 36.87 (-0.05), SUNE: 15.57 (+0.46), ACHN: 10.89 (+0.76), LOCO: 33.45 (-0.12), DWA: 20.28 (-0.55)
The 5 Best Biotech Stocks in 2014...so far
Todd Campbell, The Motley Fool - Motley Fool - Fri Sep 26, 7:35AM CDT
Since the quarter is wrapping up and investors are considering their game plan heading into year-end, let's look at biotech's biggest winners for the year, why they've rallied, and whether they make sense for your portfolio . Specifically, let's...
GILD: 96.88 (+0.72), ACHN: 10.89 (+0.76), RCPT: 61.11 (-0.96), PTCT: 37.55 (+0.48), ICPT: 216.64 (+18.56), PBYI: 221.41 (+6.22)
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma
PR Newswire - Tue Sep 16, 8:05AM CDT
The US markets on Monday, September 15 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,031.14, up 0.26% and the NASDAQ Composite closed at 4,518.90, down 1.07%. The S&P 500 finished the session 0.07% lower at 1,984.13. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 734.33, down 0.32%, whereas the index has gained 6.67% in the previous three months. Investor-Edge has initiated coverage on the following equities: Medivation Inc. (NASDAQ: MDVN), Galectin Therapeutics Inc. (NASDAQ: GALT), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), and PDL BioPharma Inc. (NASDAQ: PDLI). Free research on these five companies can be accessed at:
MDVN: 92.54 (+2.91), IRWD: 12.88 (-0.47), ACHN: 10.89 (+0.76), GALT: 5.17 (+0.29), PDLI: 8.13 (+0.50)
ACHN, IBIO, CRAY, IBCA, QLTY, PIY Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Sep 16, 6:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Achillion Pharmaceuticals Inc (NASDAQ:ACHN), Ibio Inc (NYSE:IBIO), Cray Inc (NASDAQ:CRAY), Intervest Bancshares Corp (NASDAQ:IBCA), Quality Distribution Inc (NASDAQ:QLTY), Preferredplus Trust Series Czn 1 (NYSE
PIY: 25.93 (+0.38), QLTY: 11.20 (+0.10), ACHN: 10.89 (+0.76), IBIO: 1.89 (+0.50), IBCA: 9.62 (+0.07), CRAY: 27.52 (+2.17)
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - Tue Sep 16, 4:00AM CDT
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.
TSLA: 226.35 (-3.35), XBI: 156.59 (+4.37), IBB: 260.98 (+4.51), JBLU: 11.22 (+0.92), DEO: 110.14 (+0.37), NOK: 7.80 (+0.03), YHOO: 38.12 (+0.30), EBAY: 47.88 (-2.36), PLCE: 48.23 (+0.20), TWTR: 48.23 (-1.76), MSFT: 42.74 (-0.48), AAPL: 96.26 (-1.28), REGN: 340.71 (+5.96), AMZN: 302.86 (-3.11), ABX: 13.78 (+0.23), NADL: 5.60 (+0.06), DRI: 48.36 (+0.12), CELG: 86.38 (-0.17), AA: 14.60 (+0.10), BIDU: 211.22 (+5.49), TSO: 59.81 (+1.17), GILD: 96.88 (+0.72), ACHN: 10.89 (+0.76), IWM: 107.80 (+1.20), BF.B: 83.84 (+0.23), CRM: 53.87 (+0.78)
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver
PR Newswire - Mon Sep 15, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACHN, LITB, VJET, WFM and DIS.
WFM: 36.87 (-0.05), VJET: 13.39 (+0.78), ACHN: 10.89 (+0.76), DIS: 81.74 (-0.34), LITB: 6.38 (+0.19)
Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts
at The Street - Thu Sep 11, 6:47PM CDT
As long as it's here, good things are happening every day, Cramer says.
SD: 4.57 (+0.03), RH: 76.42 (+1.44), RAX: 34.69 (-0.35), EMN: 74.34 (+0.87), OKE: 56.55 (+2.07), KORS: 72.07 (+0.65), ATK: 127.46 (+3.46), CNVR: 34.10 (+0.56), SBUX: 72.64 (+0.26), SON: 38.44 (+0.71), ACAD: 25.29 (+0.18), COH: 35.12 (-0.42), FSLR: 54.22 (+0.98), ISIS: 40.56 (+1.59), ACHN: 10.89 (+0.76), JE: 4.46 (+0.12), MTN: 82.75 (+0.62), AIG: 49.40 (-0.29), KATE: 25.52 (+0.22), TWTR: 48.23 (-1.76), TASR: 14.97 (+0.28), SWHC: 9.86 (+0.33)
Can the Rally in Achillion (ACHN) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 9:58AM CDT
Can the Rally in Achillion (ACHN) Shares Continue?
ACHN: 10.89 (+0.76)
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications
PR Newswire - Tue Sep 09, 7:35AM CDT
Today, Analysts Review released its research reports regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Deere & Company (NYSE: DE), Honeywell International Inc. (NYSE: HON), Lockheed Martin Corporation (NYSE: LMT) and L-3 Communications Holdings Inc. (NYSE: LLL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6311-100free.
LMT: 174.72 (-0.47), HON: 86.39 (+1.28), ACHN: 10.89 (+0.76), DE: 84.12 (-0.81), LLL: 109.23 (+0.14)
Most active Nasdaq-traded stocks
AP - Fri Sep 05, 2:45PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
EBAY: 47.88 (-2.36), GILD: 96.88 (+0.72), FB: 72.63 (-0.58), ACHN: 10.89 (+0.76), MSFT: 42.74 (-0.48), INTC: 30.85 (-0.42), AAPL: 96.26 (-1.28), CSCO: 22.82 (-0.14)
Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte
at The Street - Fri Sep 05, 7:55AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.
MDVN: 92.54 (+2.91), ECYT: 5.85 (+0.17), ACHN: 10.89 (+0.76), ARIA: 5.36 (-0.12), EXEL: 1.62 (+0.07)